Skip to content
devi
CERTS
Devices
Categories
Manufacturers
Importers
Certifiers
Authorities
Reps.
Representatives
Categories
/
Dental, ophthalmologic and ENT devices
/
Dental devices
/
Surgical dental devices
Surgical dental devices
Q0103
10,523 devices
Subcategories
6
Q010301
Periodontal membranes
339
devices
Q010302
Dental graft devices
349
devices
Q010303
Retrograde filling devices
0
devices
Q010304
Periodontal dressings
38
devices
Q010305
Surgical dentistry cements
49
devices
Q010399
Surgical dental devices - other
9,748
devices
Devices
Wa Bone
Chiyewon Co., LTD.
·
,
South Korea
Class III
CE/MDD
Octabone® Syringe
Chiyewon Co., LTD.
·
,
South Korea
Class III
CE/MDD
creos™ xenoform
Chiyewon Co., LTD.
·
,
South Korea
Class III
CE/MDD
NovaBone Dental Morsels
NovaBone Products, LLC
·
,
United States
Class III
CE/MDD
NTM-Cera
Zesa Tıbbi Cihazlar Med. Kim. San. Tic. Ltd. Şti
·
,
Türkiye
Class III
CE/MDD
TITAN-X Syringe
Chiyewon Co., LTD.
·
,
South Korea
Class III
CE/MDD
Amalgam Well
Crosstex (Private) Limited.
·
,
Pakistan
Class I
CE/MDR
Ice-berg∙oss™
Chiyewon Co., LTD.
·
,
South Korea
Class III
CE/MDD
Bone Instruments Curved Fig 02 3, 5/4, 5 mm
Dr.frigz International(Pvt)Ltd,
·
,
Pakistan
Class I
CE/MDR
Alpha-Bio Tec™ xenobone
Chiyewon Co., LTD.
·
,
South Korea
Class III
CE/MDD
Amalgam Instruments With Plastic Tip, Metal
Dr.frigz International(Pvt)Ltd,
·
,
Pakistan
Class I
CE/MDR
THE Graft Collagen
PURGO BIOLOGICS Inc.
·
,
South Korea
Class III
CE/MDD
3D Bond+
Augma Biomaterials
·
,
Israel
Class III
CE/MDR
×2
Active
Valid to Feb 2030
CE/MDD
WA BONE Syringe
Chiyewon Co., LTD.
·
,
South Korea
Class III
CE/MDD
THE Graft
PURGO BIOLOGICS Inc.
·
,
South Korea
Class III
CE/MDD
TITAN-X Syringe
Chiyewon Co., LTD.
·
,
South Korea
Class III
CE/MDD
creos™ xenoform
Chiyewon Co., LTD.
·
,
South Korea
Class III
CE/MDD
Ti-oss®
Chiyewon Co., LTD.
·
,
South Korea
Class III
CE/MDD
GUDID
on market
Alpha-Bio Tec™ xenobone
Chiyewon Co., LTD.
·
,
South Korea
Class III
CE/MDD
3D Bond+
Augma Biomaterials
·
,
Israel
Class III
CE/MDD
CE/MDR
×2
Active
Valid to Feb 2030
Previous
Next